Tellgen Corporation
300642StockSHE
12.95 ▲ +2.37%
12 juin 2026
3
Tellgen Corporation
12.95 ▲ +2.37%
12 juin 2026
300642StockSHE

01 / À propos

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

Arberion
Loading market data